<DOC>
	<DOC>NCT00432237</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of MK0974 compared to a placebo for acute migraine.</brief_summary>
	<brief_title>Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Patient has at least 1 year history of migraine (with or without aura) Females of childbearing years must use acceptable contraception throughout trial Patient is pregnant/breastfeeding (or is a female expecting to conceive during the study period) Patient has history or evidence of uncontrolled diabetes, or Human Immunodeficiency Virus (HIV) disease. Patient has uncontrolled cardiovascular disease Patient has major depression, other pain syndromes that might interfere with study assessments, psychiatric conditions, dementia, or significant neurological disorders (other than migraine) Patient has a history of gastric or small intestinal surgery or has a disease that causes malabsorption Patient has a history of cancer within the last 5 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>